Imazol

Clotrimazole, the active ingredient in Imazol, is a imidazole antifungal presented as a topical formulation for cutaneous use. It treats superficial fungal infections of the skin such as athlete's foot, ringworm and jock itch in adults and children. GNH USA supplies Imazol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imazol (clotrimazole) is used to treat fungal infections of the skin and related conditions. - Tinea pedis (athlete's foot): reduces itching, scaling and erythema caused by dermatophyte infection. - Tinea corporis (ringworm): clears circular erythematous lesions and prevents spread. - Tinea cruris (jock itch): alleviates inflammation and pruritus in the groin area. - Candidal skin infections: eliminates yeast overgrowth and resolves erythema and maceration.

Topical clotrimazole is generally well tolerated, but local reactions may occur.

Common Side Effects: - Burning sensation at the application site. - Mild itching or irritation. - Redness or mild rash. - Dryness or peeling of the skin. - Slight stinging during application.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., swelling, hives, difficulty breathing). - Contact dermatitis with extensive blistering. - Stevens‑Johnson syndrome or toxic epidermal necrolysis (very rare). - Persistent skin irritation despite discontinuation. - Systemic absorption leading to hepatic effects (extremely rare).

Before using Imazol, consider the following safety measures. - Avoid application on broken or inflamed skin: limit use to intact epidermis. - Do not use with other topical antifungal agents simultaneously: may increase irritation. - Discontinue if severe redness, swelling, or pain develops: seek medical advice. - Consult a healthcare professional if infection does not improve within two weeks. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Clotrimazole has limited systemic interactions, but certain combinations may affect safety or efficacy.

Major Interactions (Avoid): - Concurrent systemic azole antifungals (e.g., fluconazole) may increase systemic exposure. - Use with known hypersensitivity to imidazole compounds.

Moderate Interactions (Monitor Closely): - Application with other topical irritants (e.g., harsh soaps) may heighten skin reactions. - Use together with potent topical corticosteroids may reduce antifungal effectiveness. - Occlusive dressings over treated area can increase drug absorption and irritation risk.